DR. WALI A DANESH M.D. NPI 1598789463

NPI Information

  • NPI: 1598789463
  • Provider Name: DR. WALI A DANESH, M.D.
  • Classification: Internal Medicine - 207R00000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1611 CREEKSIDE DR STE 104
    FOLSOM, CA
    ZIP 95630
  • Phone: (916) 984-6100

Map and Directions

Get Directions

NPI Details

DR. Wali A Danesh, M.D. is an internal medicine in Folsom, CA with 32 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Wali A Danesh, M.D. NPI is 1598789463. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: EASTERN VIRGINIA MEDICAL SCHOOL
Graduation Year:1994

The provider's business location address is:

1611 CREEKSIDE DR STE 104
FOLSOM, CA
ZIP 95630-490
Phone: (916) 984-6100
Fax: (916) 984-6129

The NPI 1598789463 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection of trigger points, 3 or more muscles (HCPCS:20553)
  • Urinalysis, manual test (HCPCS:81002)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Removal of impacted ear wax (HCPCS:69210)
  • Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
  • Coronavirus vaccine 14 (HCPCS:91313)
  • Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
  • Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
  • Transitional care management services for problem of high complexity (HCPCS:99496)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS:J7613)

The enumeration date for this NPI number is 7/26/2006 and was last updated on 6/22/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineA75706CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1G65165MEDICARE UPINCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.